Operator
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited First Quarter 2021 Earnings Conference Call.
[Operator Instructions]
This conference is being recorded today, May 12, 2021. I would now like to turn the conference call over to Mr. Scott Powell, Executive Vice President of Investor Relations. Please go ahead.
Scott Powell
Executive Vice President, Investor Relations & Chief Financial Officer of Volition America, Inc.
Thank you, and welcome everyone to today s earnings conference call for VolitionRx Limited. This call will cover Volition s financial and operating results for the first quarter of 2021, along with a discussion of our recent activities and key upcoming milestones. Following our prepared remarks, we will open the conference call to a question-and-answer session. On our call today are Mr. Cameron Reynolds, President and Chief Executive Officer; Mr. Terig Hughes, our Chief Financial Officer.
Just next door is Q’ero Restaurant, Monica Szepesy s business for 20 years.
Szepesy said she s currently trying to fill three positions at her restaurant that serves South-American & Peruvian delicacies. We had three people who for one reason or another didn t show up for work yesterday… we just had to roll up our sleeves and do the job, said Szepesy, whose mother has been helping her at the restaurant as well. It means being ready for whatever, whenever, which is hard, but I think after a year of being on edge like that it starts to wear on you. Having to do multiple jobs to stay afloat is really starting to take a toll.
VolitionRx Limited Announces First Quarter 2021 Financial Results and Business Update
Conference call to discuss financial and operational results scheduled for Wednesday, May 12, at 8:00 a.m. U.S. Eastern Time
News provided by
Share this article
Strengthened the Company s leadership team to drive commercial focus
Expanded the Company s intellectual property portfolio
Initiated production of product components at scale at the Company s Silver One facility
Published three clinical papers
Continued focus on product launches and licensing in both the human and veterinary spaces
AUSTIN, Texas, May 11, 2021 /PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ( Volition ) today announced financial results and a business update for the first quarter ended March 31, 2021. Volition management will host a conference call tomorrow, May 12 at 8:00 a.m. U.S. Eastern Time to discuss these results. Conference call details may be found below.